seroprevalence


Also found in: Wikipedia.

ser·o·prev·a·lence

(ser-ō-prev'ă-lents),
Prevalence of a marker as measured by results of serologic testing.
[sero- + prevalence]

seroprevalence

[-prev′ələns]
the overall occurrence of a disease within a defined population at one time, as measured by blood tests. An example is human immunodeficiency virus seroprevalence.

seroprevalence

Immunology The proportion of a population that is seropositive–ie, has been exposed to a particular pathogen or immunogen; the seropositivity of a population is calculated as the number of individuals who produce a particular antibody divided by the total population

ser·o·prev·a·lence

(ser-ō-prev'ă-lens)
Prevalence of a marker as measured by results of serologic testing.
References in periodicals archive ?
The seroprevalence of HHV-8 varied from 12% to 24%, depending on the serologic method used to detect both HHV-8 antibodies and HHV-8 DNA.
In a June 1999 hepatitis B study conducted in North Carolina, the hepatitis B seroprevalence rate in new mothers was found to be only 0.
cruzi seroprevalence in shelter dog populations across Texas.
In fact, using data from the National Health and Nutrition Examination Survey III, which included serum samples from 13,904 participants, the investigators found that seroprevalence of HSV-2 was higher among patients with HSV-1 antibodies than among those without the antibodies, and that 76% of those with HSV-2 antibodies also had HSV-1 antibodies (J.
In this study, we determined the seroprevalence of WNV in dogs living close to humans in different environments to assess their role as sentinels of this potentially severe zoonosis.
ATLANTA -- Investigators from the Centers for Disease Control and Prevention are launching a study to determine why Helicobacter pylori seroprevalence, resistance, and reinfection rates are dramatically higher in the Alaska Native population, compared with other U.
High mean seroprevalence was found in cow herds; 105 (86.
Our hypothesis was 3-fold: 1) HEV is a possibly undiagnosed pathogen in laboratory rabbits, 2) HEV seroprevalence is unlikely in rabbits from supplier B (a SPF supplier), and 3) HEV seroprevalence might confound research.
burnetii seroprevalence estimates for dairy cattle farm residents in the Netherlands are outdated, and risk factors associated with seropositivity are seldom studied.
Recent studies have shown that the seroprevalence of CCHFV antibodies (IgG) in the general population of Greece is [approximately equal to] 4%, but large differences are seen between regions (range 0%-27%) (9-11).
Seroprevalence was already high (27% on average) in wild cervids in October 2011 in Belgium, suggesting that the virus began circulating months earlier (before August 2011).
As of September 2013, a total of 108 laboratory-confirmed infections (with 50 deaths) caused by MERS-CoV have been reported to the World Health Organization (WHO), most from Saudi Arabia (3), but data are limited on MERSCoV seroprevalence in humans (4).